Searchable abstracts of presentations at key conferences in endocrinology

ea0059p024 | Adrenal and steroids | SFEBES2018

Current management of adrenal incidentalomas- a United Kingdom single centre experience

Allsop Daniel , Burgess Neil , Saada Janak , Ahluwalia Rupa , Chipchase Allison , Myint KhinSwe

Background: Adrenal incidentalomas (AI) are asymptomatic adrenal lesions found on imaging not primarily performed to detect adrenal disease. We conducted a retrospective audit of management of AI following European Society of Endocrinology recommendation (2016).Methods: This was a retrospective review of incidentaloma referrals over 9 months (June 2017–March 2018). Cases were identified using criterion search of the referral console. Additional data...

ea0065p3 | Adrenal and Cardiovascular | SFEBES2019

A role for salivary cortisol measurement in assessing heat tolerance during exercise

Stacey Mike , House Carol , Woods David , Allsopp Adrian , Brett Stephen , Sa Daniel Roiz de

Introduction: Exercise in the heat can impose significant physiological strain and may result in incapacity, illness and death from exertional heat stroke (EHS). The adrenocortical response to exercise is known to be amplified with concurrent heat stress, suggesting the potential utility of cortisol measurement in dynamic surveillance for heat intolerance. In laboratory conditions, a standard Heat Tolerance Assessment (HTA) may be used to determine thermal tolerance to exercis...

ea0050cmw3.1 | Workshop 3: How do I. . . (1) | SFEBES2017

How do I manage . . . . the patient with thyroid dysfunction after immunotherapy?

Morganstein Daniel

Immunotherapies such as IL-2 and interferon have long been used in the treatment of certain cancers and immune mediated conditions. It has also long been recognised that their use is associated with an increased risk of autoimmune thyroid disease. Recent advances in the use of checkpoint inhibitors, such as ipilimumab and PD-1 inhibitors, in the treatment of a number of common cancers, as well as treatments such as alemtuzumab in multiple sclerosis have dramatically increased ...

ea0050apw1.3 | Tissue Engineering for Regenerative Medicine in Endocrinology | SFEBES2017

3D-Bioprinting coming of age-from cells to organs

Thomas Daniel

Over the past decade, annual spending on pharmaceutical development to treat many endocrinological systems has increased exponentially. At the same time, in spite of these huge sums invested, the average number of drugs being approved for human use has decreased to one in ten. Currently, preclinical studies to test the safety and efficiency of new drugs, use laboratory animals and traditional 2D cell culture models. Neither of these methods are completely accurate reflections ...

ea0050cmw3.1 | Workshop 3: How do I. . . (1) | SFEBES2017

How do I manage . . . . the patient with thyroid dysfunction after immunotherapy?

Morganstein Daniel

Immunotherapies such as IL-2 and interferon have long been used in the treatment of certain cancers and immune mediated conditions. It has also long been recognised that their use is associated with an increased risk of autoimmune thyroid disease. Recent advances in the use of checkpoint inhibitors, such as ipilimumab and PD-1 inhibitors, in the treatment of a number of common cancers, as well as treatments such as alemtuzumab in multiple sclerosis have dramatically increased ...

ea0050apw1.3 | Tissue Engineering for Regenerative Medicine in Endocrinology | SFEBES2017

3D-Bioprinting coming of age-from cells to organs

Thomas Daniel

Over the past decade, annual spending on pharmaceutical development to treat many endocrinological systems has increased exponentially. At the same time, in spite of these huge sums invested, the average number of drugs being approved for human use has decreased to one in ten. Currently, preclinical studies to test the safety and efficiency of new drugs, use laboratory animals and traditional 2D cell culture models. Neither of these methods are completely accurate reflections ...

ea0086bpw2.3 | New advances in neuroendocrinology | SFEBES2022

How does the pituitary decode GnRH signals?

Bernard Daniel

Gonadotropin-releasing hormone (GnRH) plays fundamental roles in the control of reproductive physiology. Perturbations in GnRH production or secretion cause infertility or subfertility. GnRH analogs are used clinically to both promote and inhibit the reproductive axis. GnRH is produced in neurons in the hypothalamus and is released in pulses into the pituitary portal system. The hormone binds to its cell surface receptor, GnRHR, on pituitary gonadotrope cells, where it stimula...

ea0063ns1.2 | (1) | ECE2019

Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring

Morganstein Daniel

Checkpoint Inhibitors have emerges as a major breakthrough in cancer therapy. Side effects are largely immune mediated, termed immune related adverse events. Whilst the majority of these respond to immunosuppressive treatment, most frequently glucocorticoids, endocrinopathies are amongst the more frequent adverse events, and usually lead to permanent hormone deficiency, requiring life long hormone replacement. There are differences in the pattern of endocrinopathy between diff...

ea0034mte7 | (1) | SFEBES2014

Who should the endocrinologist ask the ophthalmologist to review?

Ezra Daniel

Thyroid eye disease (TED), or Graves’ orbitopathy, is a common manifestation of autoimmune thyroid disease, affecting up to 30% of patients. Prompt identification of the development of TED is often difficult as the underlying inflammation of the orbital tissues and can lead to a wide range of symptoms and signs.These include extraocular muscle fibrosis leading to diplopia, orbital congestion leading to optic nerve compression and lid retraction lead...

ea0020s2.4 | β cell proliferation, survival and secretion | ECE2009

Incretin receptor signalling, β-cell proliferation and survival

Drucker Daniel

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones secreted by gut endocrine cells that act on structurally related β-cell G protein coupled receptors to trigger glucose-dependent insulin secretion. Both peptide hormones augment glucose-stimulated insulin secretion although the actions of GIP are diminished in the setting of hyperglycemia. Moreover, the two incretin hormones, and their structurally related receptor...